Amiti C. Rothstein

Cooley advised the underwriters in Apellis Pharmaceuticals’ $402.5 million follow-on offering. Apellis is a global biopharmaceutical company committed to leveraging courageous science, creativity and compassion to deliver life-changing therapies. JP Morgan, Goldman Sachs & Co., and Evercore ISI acted as joint book-running managers for the offering, while Baird and Raymond James acted as co-managers. Partners Div Gupta and Richard Segal led the Cooley team.

Cooley advised the underwriters in ADC Therapeutics’ $60 million follow-on offering. Jefferies acted as sole book-running manager for the offering. ADC Therapeutics is a commercial-stage, oncology-focused biotechnology company involved in the development of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. Partners Richard Segal and Div Gupta led the Cooley team.

Cooley advised the underwriters in Cerevel Therapeutics’ $253.8 million follow-on offering of 7,250,000 shares of its common stock at a public offering price of $35 per share and the initial purchasers in its $345.0 million Rule 144A convertible notes offering. Cerevel is a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system target receptor selective pharmacology to discover and design new therapies. Lawyers Div Gupta, Daniel Goldberg, Eric Blanchard, Mischi a Marca, Jason Savich, Minkyu Park, Amiti Rothstein, Ellie Guadiana, Matt Kong, Eric Delgado and Jordan Verrilli led the Cooley team.

Cooley advised the underwriters in Verona Pharma’s $150 million follow-on offering of 14,260,000 American depositary shares at a public offering price of $10.50 per American depositary share. Verona is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Lawyers Daniel Goldberg, Eric Blanchard, Div Gupta, Charlie Kim, Minkyu Park, Amiti Rothstein and Olivia Creser led the Cooley team.

Cooley advised the underwriters on Arbor Realty Trust’s $123.9 million offering of 7,475,000 shares at $16.57 per share. Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily loan and commercial real estate industries. Partners Daniel Goldberg, Josh Kaufman and Courtney M.W. Tygesson led the Cooley team.